Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Chen, Weiwei ^a,b   Liu, Peixin ^a   Wang, Yedong ^b   Nie, Weimin ^b   Li, Zhiwei ^b   Xu, Wen ^b   Li, Fengyi ^b   Zhou, Zhiping ^b   Zhao, Min ^b   Liu, Henggui ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SB7 H3; RNA; UNCLASSIFIED DRUG; B7 ANTIGEN; CD276 PROTEIN, HUMAN; INTEIN; ISOPROTEIN; PRIMER DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LIVER CELL CARCINOMA; MALE; MOLECULAR CLONING; MOLECULAR GENETICS; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; PROTEIN BLOOD LEVEL; RNA SPLICING; SB7 H3 GENE; SEQUENCE ANALYSIS; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; BLOOD; CHINA; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; LIVER TUMOR; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; B7 ANTIGENS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHINA; CLONING, MOLECULAR; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTEINS; LIVER NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

EID: 84885997166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076965     Document Type: Article

References (44)

1. Greenwald RJ, Freeman GJ, Sharpe AH, (2005) The B7 family revisited. Annu Rev Immunol 23: 515-548.
2. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261-268.
3. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, et al. (1999) T-cell co-stimulation through B7RP-1 and ICOS. Nature 402: 827-832.
4. Dong H, Zhu G, Tamada K, Chen L, (1999) B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5: 1365-1369.
5. Kryczek I, Wei S, Zhu G, Myers L, Mottram P, et al. (2007) Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 67: 8900-8905.
6. Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, et al. (2006) B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A 103: 10391-10396.
7. Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, et al. (2006) The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia 8: 190-198.
8. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, et al. (2001) B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2: 269-274.
9. Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, et al. (2008) Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci U S A 105: 10495-10500.
10. Suh WK, Gajewska BU, Okada H, Gronski MA, Bertram EM, et al. (2003) The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 4: 899-906.
11. Leitner J, Klauser C, Pickl WF, Stockl J, Majdic O, et al. (2009) B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. Eur J Immunol.
12. Chen W, Hou Z, Li C, Xiong S, Liu H, (2011) Cloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activation. PLoS One 6: e21341.
13. Ling V, Wu PW, Spaulding V, Kieleczawa J, Luxenberg D, et al. (2003) Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics 82: 365-377.
14. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, et al. (2007) B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A 104: 19458-19463.
15. Yamato I, Sho M, Nomi T, Akahori T, Shimada K, et al. (2009) Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 101: 1709-1716.
16. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, et al. (2006) B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 53: 143-151.
17. Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, et al. (2007) B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res 67: 7893-7900.
18. Gregorio A, Corrias MV, Castriconi R, Dondero A, Mosconi M, et al. (2008) Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. Histopathology 53: 73-80.
19. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, et al. (2008) Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 14: 5150-5157.
20. Katayama A, Takahara M, Kishibe K, Nagato T, Kunibe I, et al. (2011) Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis. Int J Oncol.
21. Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, et al. (2011) B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci 102: 1019-1024.
22. Zhang G, Hou J, Shi J, Yu G, Lu B, et al. (2008) Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology 123: 538-546.
23. Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, et al. (2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 59: 1163-1171.
24. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
25. Zhang G, Xu Y, Lu X, Huang H, Zhou Y, et al. (2009) Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer 66: 245-249.
26. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421-430.
27. Wang LH, Su L, Wang JT, (2010) Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer. Chin Med J (Engl) 123: 3545-3549.
28. Sadanandam A, Lal A, Benz SC, Eppenberger-Castori S, Scott G, et al. (2012) Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? Breast Cancer Res Treat 136: 693-703.
29. Liu HG, Chen WW, Fan ZP, Yang HY, Shi M, et al. (2007) The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clin Immunol 125: 337-345.
30. Peng JM, Tian ZJ, Liu HG, An TQ, Zhou YJ, et al. (2010) Cloning and identification of porcine programmed death 1. Vet Immunol Immunopathol 136: 157-162.
31. Wang S, Bajorath J, Flies DB, Dong H, Honjo T, et al. (2003) Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 197: 1083-1091.
32. Luo L, Chapoval AI, Flies DB, Zhu G, Hirano F, et al. (2004) B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells. J Immunol 173: 5445-5450.
33. Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, et al. (2004) Murine B7-H3 is a negative regulator of T cells. J Immunol 173: 2500-2506.
34. Luan Y, Ju J, Luo L, Zhang Z, Wang J, et al. (2012) Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection. J Viral Hepat 19: 23-31.
35. Zhang G, Wang J, Kelly J, Gu G, Hou J, et al. (2010) B7-h3 augments the inflammatory response and is associated with human sepsis. J Immunol 185: 3677-3684.
36. Zhou YH, Chen YJ, Ma ZY, Xu L, Wang Q, et al. (2007) 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells. Tissue Antigens 70: 96-104.
37. Steinberger P, Majdic O, Derdak SV, Pfistershammer K, Kirchberger S, et al. (2004) Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 172: 2352-2359.
38. Zhang GB, Chen YJ, Shi Q, Ma HB, Ge Y, et al. (2004) Human recombinant B7-H3 expressed in E. coli enhances T lymphocyte proliferation and IL-10 secretion in vitro. Acta Biochim Biophys Sin (Shanghai) 36: 430-436.
39. Wang L, Fraser CC, Kikly K, Wells AD, Han R, et al. (2005) B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol 35: 428-438.
40. Sun X, Vale M, Leung E, Kanwar JR, Gupta R, et al. (2003) Mouse B7-H3 induces antitumor immunity. Gene Ther 10: 1728-1734.
41. Arigami T, Narita N, Mizuno R, Nguyen L, Ye X, et al. (2010) B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg 252: 1044-1051.
42. Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, et al. (2009) Expression of immunosuppresive b7-h3 ligand by hormone-treated prostate cancer tumors and metastases. Clin Cancer Res 15: 2174-2180.
43. Kakoulidou M, Wang X, Zhao X, Pirskanen R, Lefvert AK, (2007) Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis. J Neuroimmunol 185: 150-161.
44. Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee KH, et al. (2009) Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 137: 682-690.